A phase II clinical trial of carbon-ion radiotherapy for pelvic recurrent rectal cancer in patients with prior pelvic carbon-ion irradiatio
Phase 2
- Conditions
- pelvic recurrent rectal cancer
- Registration Number
- JPRN-UMIN000022731
- Lead Sponsor
- ational Institute for Quantum and Radiological Sciences and Technology QST hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 71
Inclusion Criteria
Not provided
Exclusion Criteria
1. Diameter of treatment volume longer than 15cm 2.Patient receive chemotherapy within 2 weeks 3. If they have an open wound or a active inflammatory disease 4. If they have a concomitant malignancy 5. If they have a severe heart diseases, a severe cerebrovascular disorder, a severe diabetes, angina pectoris, cardiac infarction. 6.In appropriate for this clinical study because of mental disorder, or other severe concurrent disease. 7.Adults and minors who do not have the capacity to consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 3 years survival rates
- Secondary Outcome Measures
Name Time Method